In the news

Biorce Closes Series A of €43.8 to Accelerate Clinical Trials

EU-Startups.com news article about Biorce.

About Biorce

Biorce is an AI healthtech startup, building defensible AI solutions for clinical trial development. Its platform, Aika, is a continuous intelligent layer, from protocol decision to regulatory submission, enabling fewer amendments and a dramatic reduction of cost and time.

Media contact

Lynn Caroline Broeker
PR & Media collaborations
lynn.broeker@biorce.com

Get the inside track on clinical trial innovation Insights that pharma leaders actually read. No fluff.

@2026 Biorce | All Rights Reserved

Partners with

Get the inside track on clinical trial innovation Insights that pharma leaders actually read. No fluff.

@2026 Biorce | All Rights Reserved

Partners with

Get the inside track on clinical trial innovation Insights that pharma leaders actually read. No fluff.

Partners with

@2026 Biorce | All Rights Reserved